| 2024年年报 | 2023年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 动保添加剂及制剂(元) | 185,986,730.09 | 197,032,780.72 |
| 动保原料药(元) | 1,831,157,445.81 | 1,637,754,870.39 |
| 关键医药中间体(元) | 1,130,289,524.68 | 1,121,027,926.50 |
| 医药原料药(元) | 2,477,466,612.98 | 2,217,185,839.84 |
| 医药制剂(元) | 213,835,927.67 | 146,966,832.77 |
| 其他(元) | 28,256,099.93 | 7,129,457.70 |
| 营业成本(元) | ||
| 动保添加剂及制剂(元) | 173,542,068.28 | 177,230,151.29 |
| 动保原料药(元) | 1,485,880,120.07 | 1,299,094,278.60 |
| 关键医药中间体(元) | 755,047,095.42 | 739,307,574.45 |
| 医药原料药(元) | 1,774,934,934.93 | 1,736,435,384.12 |
| 医药制剂(元) | 190,319,875.51 | 128,885,115.99 |
| 其他(元) | 26,521,195.27 | 7,216,324.63 |
| 毛利(元) | ||
| 动保添加剂及制剂(元) | 12,444,661.81 | 19,802,629.43 |
| 动保原料药(元) | 345,277,325.74 | 338,660,591.79 |
| 关键医药中间体(元) | 375,242,429.26 | 381,720,352.05 |
| 医药原料药(元) | 702,531,678.05 | 480,750,455.72 |
| 医药制剂(元) | 23,516,052.16 | 18,081,716.78 |
| 其他(元) | 1,734,904.66 | -86,866.93 |
| 毛利率(%) | ||
| 动保添加剂及制剂(%) | 6.69 | 10.05 |
| 动保原料药(%) | 18.86 | 20.68 |
| 关键医药中间体(%) | 33.20 | 34.05 |
| 医药原料药(%) | 28.36 | 21.68 |
| 医药制剂(%) | 11.00 | 12.30 |
| 其他(%) | 6.14 | -1.22 |
| 收入构成(%) | ||
| 动保添加剂及制剂(%) | 3.17 | 3.70 |
| 动保原料药(%) | 31.21 | 30.74 |
| 关键医药中间体(%) | 19.27 | 21.04 |
| 医药原料药(%) | 42.23 | 41.62 |
| 医药制剂(%) | 3.64 | 2.76 |
| 其他(%) | 0.48 | 0.13 |
| 毛利构成(%) | ||
| 动保添加剂及制剂(%) | 0.85 | 1.60 |
| 动保原料药(%) | 23.64 | 27.33 |
| 关键医药中间体(%) | 25.69 | 30.81 |
| 医药原料药(%) | 48.09 | 38.80 |
| 医药制剂(%) | 1.61 | 1.46 |
| 其他(%) | 0.12 | -0.01 |